AGT and cardiac hypertrophy: Yang et al. [8] found that injecting angiotensin II (Ang II) usingsubcutaneously implanted osmotic minipumps at a dose of 1500 ng/kg/min for 7 daysin 10–12 week-old male mice led to myocardial hypertrophy, cardiac fibrosis, andinflammation.